TELA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 105999 min ago

@ $7.08

Išleistas: 13 vas. 2024 @ 17:17

Grąža: -37.15%

Ankstesnis signalas: vas. 6 - 20:53

Ankstesnis signalas: Pardavimas

Grąža: 1.29 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Šios dienos apimtis	57 153.00
Vidutinė apimtis	125 360
Rinkos kapitalizacija	109.71M
EPS	$0 ( 2024-03-21 )
Kita pelno data	( $-0.480 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.18
ATR14	$0.0120 (0.27%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Firestone Gregory A.	Sell	119	Common Stock
2024-03-31	Koblish Antony	Sell	385	Common Stock
2024-03-31	Talmo Paul	Sell	190	Common Stock
2024-03-31	Smeykal Megan	Sell	96	Common Stock
2024-03-31	Murphy Peter C.	Sell	163	Common Stock

INSIDER POWER
54.62
Last 99 transactions
Buy: 1 093 142 \| Sell: 280 600

Tūris Koreliacija

Ilgas: -0.13 (neutral)

Trumpas: -0.20 (neutral)

Signal:(56.528) Neutral

TELA Bio Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
GGAL	0.923
AVEO	0.922
ITMR	0.921
FRGI	0.912
EDUT	0.91
EWEB	0.91
BKCH	0.909
HZNP	0.907
RBNC	0.906
FCBP	0.902

10 Labiausiai neigiamai susiję koreliacijos
RDHL	-0.918
LARK	-0.907
PCRX	-0.907
SLDP	-0.89
THTX	-0.889
NTLA	-0.885
ENPH	-0.884
LLNW	-0.88
MARK	-0.879
XFOR	-0.878

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

TELA Bio Inc Koreliacija - Valiuta/Žaliavos

-0.63
( weak negative )

-0.19
( neutral )

0.00
( neutral )

0.63
( weak )

TELA Bio Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$58.45M
Bruto pelnas:	$40.11M (68.62 %)
EPS:	$-2.04

FY	2023
Pajamos:	$58.45M
Bruto pelnas:	$40.11M (68.62 %)
EPS:	$-2.04

FY	2022
Pajamos:	$41.42M
Bruto pelnas:	$27.04M (65.30 %)
EPS:	$-2.73

FY	2021
Pajamos:	$29.46M
Bruto pelnas:	$19.12M (64.88 %)
EPS:	$-2.57

Financial Reports:

No articles found.

TELA Bio Inc

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.